Company Overview and News

21
DSW, L Brands, Vishay Intertechnology, Cypress Semiconductor and ON Semiconductor highlighted as Zacks Bull and Bear of the Day

2018-09-20 zacks
Chicago, IL – September 20, 2018 – Zacks Equity Research highlights DSW Inc. (DSW - Free Report) as the Bull of the Day, L Brands, Inc. (LB - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Vishay Intertechnology, Inc. (VSH - Free Report) , Cypress Semiconductor Corporation (CY - Free Report) and ON Semiconductor Corporation (ON - Free Report) .
CY DSW VSH AMD LB FWRD ON AMWD HPE RCKY

22
Zacks Market Edge Highlights: Global X Greek ETF, Royal Caribbean, Norwegian Cruise Line Holdings, American Airlines and International Consolidated

2018-09-20 zacks
Chicago, IL – September 20, 2018 – Zacks Market Edge is a podcast hosted weekly by Zacks Stock Strategist Tracey Ryniec. Every week, Tracey will be joined by guests to discuss the hottest investing topics in stocks, bonds and ETFs and how it impacts your life. To listen to the podcast, click here: (https://www.zacks.com/stock/news/323895/is-the-greek-crisis-finally-over)
NCLH UNP NTRS NTRSP AMD LB AMWD HPE RCKY

27
Zacks.com highlights: Champions Oncology, STAAR Surgical, Boingo Wireless, Verso and BioSpecifics Technologies

2018-09-20 zacks
Chicago, IL – September 20, 2018 - Stocks in this week’s article include: Champions Oncology Inc. (CSBR - Free Report) , STAAR Surgical Co. (STAA - Free Report) , Boingo Wireless Inc. (WIFI - Free Report) , Verso Corp. (VRS - Free Report) and BioSpecifics Technologies Corp. (BSTC - Free Report) .
VRSZQ VRSZ VRS UNP NTRSP VRSZW AMD LB HPE RCKY CSBR BSTC NTRS WIFI AMWD

22
Zacks Investment Ideas feature highlights: Tilray

2018-09-20 zacks
Chicago, IL – September 20, 2018 – Today, Zacks Investment Ideas feature highlights Features: Tilray (TLRY - Free Report) .
UNP NTRS NTRSP AMD LB FWRD AMWD TLRY HPE RCKY

26
The Zacks Analyst Blog Highlights: Advanced Micro Devices, Intel, Cisco, Hewlett Packard Enterprise and NVIDIA

2018-09-20 zacks
Chicago, IL – September 20, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Advanced Micro Devices (AMD - Free Report) , Intel (INTC - Free Report) , Cisco (CSCO - Free Report) , Hewlett Packard Enterprise (HPE - Free Report) and NVIDIA (NVDA - Free Report) .
UNP NTRS NTRSP AMD NVDA LB INTC FWRD AMWD HPE RCKY

26
The Zacks Analyst Blog Highlights: American Woodmark, Guess', Rocky Brands, W.W. Grainger and Caterpillar

2018-09-20 zacks
Chicago, IL – September 20, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include American Woodmark Corp. (AMWD - Free Report) , Guess', Inc. (GES - Free Report) , Rocky Brands, Inc. (RCKY - Free Report) , W.W.
HLX CATR CAT GES AMD SIVB LB FWRD LGNDZ RCKY HPE GWW LGNZZ LGNYZ LGND HEAR LGNXZ AMWD

23
The Zacks Analyst Blog Highlights: Microsoft, Union Pacific, Danaher, Travelers and Northern Trust

2018-09-20 zacks
Chicago, IL – September 20, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Microsoft (MSFT - Free Report) , Union Pacific (UNP - Free Report) , Danaher (DHR - Free Report) , Travelers (TRV - Free Report) and Northern Trust (NTRS - Free Report) .
NTRS UNP NTRSP MSFT CSX AMD LB FWRD AMWD DHR HPE RCKY

26
The Zacks Analyst Blog Highlights: Regeneron Pharmaceuticals, Celgene, Sanofi and Gilead Sciences

2018-09-20 zacks
Chicago, IL – September 20, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Regeneron Pharmaceuticals (REGN - Free Report) , Celgene Corporation (CELG - Free Report) , Sanofi (SNY - Free Report) and Gilead Sciences, Inc.
REGN CELGZ GILD AMD LB VKTX FWRD SNY HPE RCKY VKTXW CELG AMWD

29
Zacks.com highlights: G-III Apparel Group, Target, Regeneron Pharmaceuticals, AMETEK and Xilinx

2018-09-20 zacks
Chicago, IL – September 20, 2018 - Stocks in this week’s article include: G-III Apparel Group, Ltd. (GIII - Free Report) , Target Corporation (TGT - Free Report) , Regeneron Pharmaceuticals, Inc. (REGN - Free Report) , AMETEK Inc. (AME - Free Report) and Xilinx Inc. (XLNX - Free Report) .
XLNX REGN TGT AME AMD LB FWRD GIII AMWD HPE RCKY

27
Zacks Earnings Trends Highlights: Apple, Alphabet and Facebook

2018-09-20 zacks
Chicago, IL – September 20, 2018 – Zacks Director of Research Sheraz Mian says, “Total earnings for the S&P 500 index are expected to be up +17.6% in Q3 from the same period last year on +7.3% higher revenues, the 6th time in the last 7 quarters of double-digit earnings growth.”
FB GOOGL AAPL AMD LB FWRD AMWD HPE RCKY

4
Wall Street Resilient to Trade Jitters: Top 5 Gainers

2018-09-19 zacks
Let’s admit that a trade war has become less of a concerning factor for most stock-market investors. They have chosen to look past US-China trade conflict as tariffs on both US and Chinese goods are not as bad as feared.
CATR GWW CAT GES AMWD RCKY

2
American Paychecks Are Getting Fatter: 5 Top Gainers

2018-09-17 zacks
Bigger paychecks are coming in for millions of Americans, with August registering the fastest wage growth since 2009, suggesting tighter labor market conditions. The U.S. economy added jobs for the 95th straight month in August, but higher pay means companies are in tough competition for quality workers. Several business houses complained that they can’t find skilled labor and may need to raise wages considerably to draw and retain skilled labor.
GES WTW MBUU JOUT RCKY

15
7 Low Price-to-Sales Stocks Poised for Value-Based Growth

2018-09-17 zacks
When considering valuation metrics, price-to-earnings ratio has always been the obvious choice as calculations based on earnings are easy and come in handy. However, price-to-sales has emerged as a convenient tool to determine the value of stocks that are incurring losses or are in an early cycle of development, generating meager or no profits. While a loss-making company with a negative price-to-earnings ratio falls out of investor favor, its price-to-sales could indicate the hidden strength of its business.
CVG MT GTS MT INT UNFI RCKY

5
Rocky Brands Sees Hammer Chart Pattern: Time to Buy?

2018-09-14 zacks
Rocky Brands, Inc. (RCKY - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because RCKY recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom.
OXY RCKY

 
Carter's in Crossroads: Can Strategies Keep Hurdles at Bay?

2018-09-05 zacks
Carter’s Inc. (CRI - Free Report) is among the few stocks that are displaying mixed sentiments. We remain optimistic on the stock, given its solid surprise trend, robust outlook for 2018 and long-term strategies. However, softness in the company’s wholesale business due to the liquidation of its key wholesale customer, Toys “R” Us, keep us on the sidelines. Evidently, the company’s shares have declined 9.
DECK WWW CRI RCKY

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to RCKY / Rocky Brands, Inc. on message board site Silicon Investor.

Rocky Brands RCKY Rocky Brands RCKY Rocky Brands RCKY
CUSIP: 774515100